Correlation Between Dianthus Therapeutics and Alumis Common

Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Alumis Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Alumis Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dianthus Therapeutics and Alumis Common Stock, you can compare the effects of market volatilities on Dianthus Therapeutics and Alumis Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Alumis Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Alumis Common.

Diversification Opportunities for Dianthus Therapeutics and Alumis Common

0.77

Correlation Coefficient

Dianthus Therapeutics  Alumis Common

Poor diversification

The 3 months correlation between Dianthus and Alumis is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Alumis Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alumis Common Stock and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Alumis Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alumis Common Stock has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Alumis Common go up and down completely randomly.

Pair Corralation between Dianthus Therapeutics and Alumis Common

Given the investment horizon of 90 days Dianthus Therapeutics is expected to generate 0.66 times more return on investment than Alumis Common. However, Dianthus Therapeutics is 1.51 times less risky than Alumis Common. It trades about -0.12 of its potential returns per unit of risk. Alumis Common Stock is currently generating about -0.13 per unit of risk. If you would invest  2,812  in Dianthus Therapeutics on September 26, 2024 and sell it today you would lose (522.00) from holding Dianthus Therapeutics or give up 18.56% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Dianthus Therapeutics  vs.  Alumis Common Stock

Dianthus Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Alumis Common Stock

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Alumis Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Dianthus Therapeutics and Alumis Common

The main advantage of trading using opposite Dianthus Therapeutics and Alumis Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Alumis Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alumis Common will offset losses from the drop in Alumis Common's long position.

The idea behind Dianthus Therapeutics and Alumis Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.